Leucine-rich repeat and fibronectin type III domain containing 5 (LRFN5) and olfactomedin 4 (OLFM4) have been suggested as significant risk factors for MDD in recent studies on genome-wide association (GWAS) and copy number variation [7–9]. Here, OLFM4 is linked to major depressive disorder.